1887

n CME : Your SA Journal of CPD - Botulinum toxin for the treatment of migraine and other primary headache disorders : main article

USD

 

Abstract

Botulinum toxin offers a new treatment option for patients suffering from chronic pain syndromes including migraine and tension-type headache. <br>Headache patients often suffer greatly as a result of sideeffects of the drugs used as prophylactic agents. These can include dizziness, fatigue, weight gain, hair loss and loss of libido. BoNTA does not cause any of these sideeffects and to date no organic damage or allergic complications have been reported. <br>The long duration of action also has the added benefit that patients do not need to take medication on a daily basis. <br>These factors make this a treatment with a high safety profile and high patient acceptability. <br>In the treatment of headache there are opinion differences on dosages, areas of injection and patient selection. Comparative studies with standard treatments are still needed. <br>Currently therefore the use of BoNTA in the treatment of headache is only justified after all standard therapeutic procedures have been exhausted and only after evaluation in specialist centres.

Loading

Article metrics loading...

/content/m_cme/23/7/EJC62995
2005-07-01
2016-12-08
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error